Australia markets open in 1 hour 14 minutes

Navidea Biopharmaceuticals, Inc. (NAVB)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.0000-0.0300 (-100.00%)
At close: 11:06AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-1,182
-15,177
-11,731
-10,722
-10,948
Depreciation & amortisation
108.184
95.819
76.954
70.393
144.512
Stock-based compensation
31.069
301.351
471.262
230.521
232.058
Change in working capital
-56.661
5,118
947.166
1,840
1,122
Inventory
-316.94
-459.195
18.643
-169.798
0
Accounts payable
332.114
701.221
259.6
49.648
687.351
Other working capital
-9,907
-9,377
-10,548
-8,588
-9,411
Other non-cash items
-536.252
610.385
284.661
401.743
34.388
Net cash provided by operating activities
-9,714
-8,987
-10,218
-8,174
-9,355
Cash flows from investing activities
Investments in property, plant and equipment
-193.308
-390.349
-329.424
-413.87
-56.7
Purchases of investments
-
-
-
-
0
Sales/maturities of investments
-
-
-
0
800
Net cash used for investing activities
-701.106
-390.349
-329.424
-412.828
770.425
Cash flows from financing activities
Debt repayment
-908.275
-518.089
-491.775
-368.553
-359.061
Common stock issued
643.789
0.03
4.346
4,443
7,087
Other financing activities
-139.762
-1,013
-87.322
-205.05
-572.271
Net cash used provided by (used for) financing activities
995.752
7,142
12,108
10,210
6,156
Net change in cash
-735.969
-2,235
1,560
1,623
-2,429
Cash at beginning of period
4,601
4,231
2,670
1,047
3,476
Cash at end of period
3,865
1,996
4,231
2,670
1,047
Free cash flow
Operating cash flow
-9,714
-8,987
-10,218
-8,174
-9,355
Capital expenditure
-193.308
-390.349
-329.424
-413.87
-56.7
Free cash flow
-9,907
-9,377
-10,548
-8,588
-9,411